| Cardiac Imaging and Diagnostics | Lifetime | 65 | US 40 | 99.86 |
| Cardiovascular Disease and Adiposity | Lifetime | 37 | US 28 | 99.70 |
| Lipoproteins and Cardiovascular Health | Lifetime | 60 | US 36 | 99.65 |
| Cardiovascular Function and Risk Factors | Lifetime | 214 | US 133 | 99.57 |
| Acute Myocardial Infarction Research | Lifetime | 130 | US 76 | 99.57 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 135 | US 63 | 99.41 |
| Cardiovascular Health and Risk Factors | Lifetime | 48 | US 34 | 99.14 |
| Cardiovascular Health and Disease Prevention | Lifetime | 170 | US 82 | 99.03 |
| Blood Pressure and Hypertension Studies | Lifetime | 282 | US 129 | 99.05 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 427 | US 208 | 98.86 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 366 | US 158 | 98.32 |
| Coronary Interventions and Diagnostics | Lifetime | 587 | US 250 | 98.35 |
| Cardiac Health and Mental Health | Lifetime | 332 | US 179 | 97.66 |
| Smoking Behavior and Cessation | Lifetime | 353 | US 252 | 96.98 |
| Cardiovascular and exercise physiology | Lifetime | 672 | US 241 | 97.31 |
| Biomarkers in Disease Mechanisms | Lifetime | 185 | US 52 | 93.60 |
| Physical Activity and Health | Lifetime | 935 | US 350 | 94.90 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 505 | US 128 | 90.78 |
| Aortic Thrombus and Embolism | Lifetime | 221 | US 96 | 85.05 |
| Heart rate and cardiovascular health | Lifetime | 236 | US 79 | 86.44 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 4 | US 3 | 99.92 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 8 | US 5 | 99.24 |
| Acute Myocardial Infarction Research | 2021-2025 | 18 | US 7 | 99.54 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 14 | US 6 | 99.63 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 11 | US 8 | 99.11 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 47 | US 19 | 98.29 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 71 | US 30 | 98.47 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 178 | US 54 | 97.86 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 70 | US 22 | 96.77 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 328 | US 133 | 97.64 |
| Diabetes Treatment and Management | 2021-2025 | 381 | US 129 | 95.84 |
| Coronary Interventions and Diagnostics | 2021-2025 | 363 | US 83 | 96.00 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 39 | US 12 | 89.55 |
| Smoking Behavior and Cessation | 2021-2025 | 191 | US 128 | 94.29 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 339 | US 69 | 92.61 |
| Cardiac Health and Mental Health | 2021-2025 | 322 | US 112 | 91.26 |
| Advanced X-ray and CT Imaging | 2021-2025 | 951 | US 208 | 86.60 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 211 | US 71 | 74.90 |
| Aortic Thrombus and Embolism | 2021-2025 | 41 | US 13 | 74.66 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 273 | US 15 | 67.32 |
| Data-Driven Disease Surveillance | 2021-2025 | 613 | US 205 | 66.56 |
| Pharmacology and Obesity Treatment | 2021-2025 | 931 | US 346 | 59.29 |
